Deferred Tax Assets, Valuation Allowance of PALISADE BIO, INC. from 31 Dec 2011 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
PALISADE BIO, INC. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2011 to 31 Dec 2024.
  • PALISADE BIO, INC. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $32,468,000, a 12% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

PALISADE BIO, INC. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $32,468,000 +$3,516,000 +12% 31 Dec 2024 10-K 24 Mar 2025 2024 FY
Q4 2023 $28,952,000 +$2,277,000 +8.5% 31 Dec 2023 10-K 24 Mar 2025 2024 FY
Q4 2022 $26,675,000 +$3,853,000 +17% 31 Dec 2022 10-K 26 Mar 2024 2023 FY
Q4 2021 $22,822,000 +$12,804,000 +128% 31 Dec 2021 10-K 22 Mar 2023 2022 FY
Q4 2020 $10,018,000 -$36,667,253 -79% 31 Dec 2020 10-K 17 Mar 2022 2021 FY
Q4 2019 $46,685,253 +$455,994 +0.99% 31 Dec 2019 10-K 22 Mar 2021 2020 FY
Q4 2018 $46,229,259 +$2,741,659 +6.3% 31 Dec 2018 10-K 27 Mar 2020 2019 FY
Q4 2017 $43,487,600 -$19,254,602 -31% 31 Dec 2017 10-K 22 Mar 2019 2018 FY
Q4 2016 $62,742,202 +$6,810,088 +12% 31 Dec 2016 10-K 02 Apr 2018 2017 FY
Q4 2015 $55,932,114 +$7,600,737 +16% 31 Dec 2015 10-K 23 Mar 2017 2016 FY
Q4 2014 $48,331,377 +$5,625,530 +13% 31 Dec 2014 10-K 14 Mar 2016 2015 FY
Q4 2013 $42,705,847 +$3,933,543 +10% 31 Dec 2013 10-K 16 Mar 2015 2014 FY
Q4 2012 $38,772,304 +$4,042,898 +12% 31 Dec 2012 10-K 10 Mar 2014 2013 FY
Q4 2011 $34,729,406 31 Dec 2011 10-K 15 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.